Browse studies

Find your next paid study

27,292 recruiting studies available now

Chorionic Gonadotropin to Improve Rehabilitation After Brain Injury - The COGNI-REHAB Study

The COGNI-REHAB Trial is a single-site, phase O/I, randomized, double-blind, placebo-controlled study of human chorionic gonadotropin (hCG; choriogonadotropin …

Traumatic Brain Injury

Estimated

~$150 – $2,700

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07557615

Observational

A Pragmatic, Single-blind, Randomized Crossover Trial Testing the Effectiveness of Autonomous Remote Patient Peripheral Edema Monitoring and Reporting in HEART FailurE Compared to conventionaL remoTe Patient Monitoring.

This pragmatic randomized crossover trial looks at the effect(s) of using a remote patient monitoring device (Heartfelt device) with health alerts to monitor t…

Heart FailureChronic Heart Failure

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Heartfelt TechnologiesNCT06222099

Phase 1

A Phase II Trial of MOR Antagonism With Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma (MORALE-MM)

This first-in-human study will evaluate the safety, clinical activity, and immunologic effects of combining axelopran with nivolumab in patients with PD-1-refr…

Unresectable Cutaneous Melanoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

John KirkwoodNCT07631325

Phase 1

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine in Subjects With Advanced Solid Tumors

This is a phase 1 dose escalation trial of monotherapy misetionamide (also known as GP-2250) currently enrolling patients with platinum-resistant ovarian cance…

Ovarian Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Persevere Therapeutics Inc.NCT03854110

Phase 2

Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)

This prospective, two-part, single-arm, phase II trial is designed to evaluate whether the use of definitive radiation to the primary lung lesion prolongs prog…

Non Small Cell Lung Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Medical College of WisconsinNCT06305715

Phase 1

An Open-Label, Phase 1/2 Dose Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, PK and Clinical Activity of FMC-376 Monotherapy and in Combination With Pembrolizumab in Participants With KRAS G12C Mutated Advanced Solid Tumors

The goal of this clinical trial is to evaluate FMC-376 monotherapy and in combination with pembrolizumab in participants with advanced solid tumors with KRAS G…

Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Frontier Medicines CorporationNCT06244771

A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)

The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult p…

Traumatic Brain Injury

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Hoffmann-La RocheNCT07455136

Observational

Tailoring a Telemedicine Hypertension Management Intervention for Black Patients

Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-…

Hypertension

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT06593119

Phase 3

A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes

This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less tha…

Diabetes Mellitus, Type 2

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07668336

Phase 1

Army-Suicide Prevention Research on Implementation in the National Guard (Army-SPRING)

Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monito…

Suicide

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of PennsylvaniaNCT06547008

Phase 1

MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)

This is a single-center, open-label clinical study designed to evaluate alpha-synuclein (ASYN) deposition in the brain of participants with Parkinson's disease…

Parkinsons Disease (PD)Healthy Elderly Volunteers

Estimated

~$500 – $10,500

Actual pay is set by the research site.

XingImaging, LLCNCT07880379

Phase 2

Abiraterone/Prednisone + Standard ADT vs Standard ADT for Prostate Cancer Patients With PSMA-Positive Conventional Imaging Negative Pelvic Lymphadenopathy

The advent of PSMA-PET has improved sensitivity and specificity in staging prostate cancer, particularly in intermediate- and high-risk disease. This has creat…

Prostate Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of NebraskaNCT07237269